<DOC>
	<DOCNO>NCT00962195</DOCNO>
	<brief_summary>Purple Sweet Potato juice ( PSP-juice ) juice base purple-fleshed sweet potato concentrate , contain high level anthocyanins . Purple-fleshed sweet potato attract attention industry scientist due multiple physiological function radical-scavenging , ACE-inhibitory α-glucosidase inhibitory activity vitro , also hepato-protective , antihypertensive antihyperglycemic effect vivo . Previous study Japanese subject show potential beneficial effect PSP beverages liver function blood pressure volunteer impair hepatic function and/or hypertension . The main objective study examine effect PSP-juice liver enzymes blood pressure . The secondary objective examine effect PSP-juice juice insulin resistance .</brief_summary>
	<brief_title>The Effect Purple Sweet Potato ( PSP ) -Juice Liver Enzymes Blood Pressure</brief_title>
	<detailed_description>Study design : The study design randomize , parallel , placebo-controlled , double-blind study . Study population : 40 healthy adult female and/or male subject , 40-70 yr old BMI 25-35 kg/m2 , mildly elevate serum liver enzyme , high normal blood pressure mild hypertension . Intervention : Daily oral intake 3x 125 ml PSP-juice control juice period 8 week . Main study parameters/endpoints : Liver enzyme ( GGT , ALAT , ASAT ) , blood pressure , glucose , insulin , haematology serum clinical chemical profile</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<criteria>Healthy assess : Health Lifestyle Questionnaire , result pre study laboratory test blood Males/Females age 4070 year ( boundary include ) Day 01 study Body Mass Index ( BMI ) 2535 ( boundary include ) kg/m2 Liver enzymes reference value GGT ≥ 45 IU/L ( male ) ≥ 35 IU/L ( female ) , and/or ASAT ≥ 45 IU/L ( male female ) , and/or ALAT ≥ 50 IU/L ( male ) ≥ 40 IU/L ( female ) Blood pressure ( automated measurement site ) : systolic blood pressure 130159 mm Hg ( boundary include ) and/or diastolic blood pressure 8599 mm Hg ( boundary include ) Voluntary participation Having give write informed consent Willing comply study procedure Willing give blood/plasma donation study Willing accept use nameless data , include publication , confidential use storage data least 15 year Willing accept disclosure financial benefit participation study authority concern . Participation clinical trial include blood sample and/or administration substance 90 day Day 01 study Participation noninvasive clinical trial 30 day Day 01 study , include blood sample and/or oral , intravenous , inhalatory administration substance Having history medical surgical event may significantly affect study outcome Any concomitant medication , exception occasional use paracetamol tablet , may influence outcome study ( judge medical investigator ) Food allergy/intolerance Alcohol consumption &gt; 28 units/week male &gt; 21 units/week female Smoking &gt; 10 cigarette per day Reported unexplained weight loss gain &gt; 2 kg month prior pre study screen Reported slimming medically prescribe diet Participation night shift work Pregnant lactate wish become pregnant period study Personnel TNO Quality Life , partner first second degree relatives Not general practitioner Not willing accept informationtransfer concern participation study , information regard his/her health , like laboratory result , finding anamnesis physical examination eventual adverse event general practitioner .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>health</keyword>
	<keyword>blood pressure</keyword>
	<keyword>liver enzyme</keyword>
	<keyword>insulin resistance</keyword>
</DOC>